• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一所高复杂性大学医院实施脓毒症代码的初始临床结果及预后变量

Initial clinical outcomes and prognostic variables in the implementation of a Code Sepsis in a high complexity University Hospital.

作者信息

Ramasco F, Figuerola A, Mendez R, Rodríguez Serrano D, von Wernitz A, Hernández-Aceituno A, Sáez C, Cardeñoso L, Martin E, García-Vázquez N, de Las Cuevas C, Pascual N, Bautista A, Jiménez D, Fernández G, Leal A, Vinuesa M, Pizarro A, di Martino M, Del Campo L, García Sanz I, Chicot M, Barrios A, Rubio M J

机构信息

Fernando Ramasco, Anesthesiology and Surgical Critical Care Departament, University Hospital of La Princesa, C/ Diego de León 62, Madrid, 28006, Spain.

出版信息

Rev Esp Quimioter. 2019 Jun;32(3):238-245. Epub 2019 Apr 9.

PMID:30968675
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6609936/
Abstract

OBJECTIVE

To assess the impact of the first months of application of a Code Sepsis in a high complexity hospital, analyzing patient´s epidemiological and clinical characteristics and prognostic factors.

METHODS

A long-term observational study was carried out throughout a consecutive period of seven months (February 2015 - September 2015). The relationship with mortality of risk factors, and analytic values was analyzed using uni- and multivariate analyses.

RESULTS

A total of 237 patients were included. The in-hospital mortality was 24% at 30 days and 27% at 60 days. The mortality of patients admitted to Critical Care Units was 30%. Significant differences were found between the patients who died and those who survived in mean levels of creatinine (2.30 vs 1.46 mg/dL, p <0.05), lactic acid (6.10 vs 2.62 mmol/L, p <0.05) and procalcitonin (23.27 vs 12.73 mg/dL, p<0.05). A statistically significant linear trend was found between SOFA scale rating and mortality (p<0.05). In the multivariate analysis additional independent risk factors associated with death were identified: age > 65 years (OR 5.33, p <0.05), lactic acid > 3 mmol/L (OR 5,85, p <0,05), creatinine > 1,2 mgr /dL (OR 4,54, p <0,05) and shock (OR 6,57, P <0,05).

CONCLUSIONS

The epidemiological, clinical and mortality characteristics of the patients in our series are similar to the best published in the literature. The study has identified several markers that could be useful at a local level to estimate risk of death in septic patients. Studies like this one are necessary to make improvements in the Code Sepsis programs.

摘要

目的

评估在一家高复杂性医院应用脓毒症规范头几个月的影响,分析患者的流行病学和临床特征以及预后因素。

方法

在连续七个月(2015年2月至2015年9月)期间进行了一项长期观察性研究。使用单变量和多变量分析来分析危险因素、分析值与死亡率之间的关系。

结果

共纳入237例患者。30天内住院死亡率为24%,60天内为27%。重症监护病房收治患者的死亡率为30%。死亡患者和存活患者在肌酐平均水平(2.30 vs 1.46mg/dL,p<0.05)、乳酸(6.10 vs 2.62mmol/L,p<0.05)和降钙素原(23.27 vs 12.73mg/dL,p<0.05)方面存在显著差异。在序贯器官衰竭评估(SOFA)量表评分与死亡率之间发现了具有统计学意义的线性趋势(p<0.05)。在多变量分析中,确定了与死亡相关的其他独立危险因素:年龄>65岁(比值比[OR]5.33,p<0.05)、乳酸>3mmol/L(OR 5.85,p<0.05)、肌酐>1.2mg/dL(OR 4.54,p<0.05)和休克(OR 6.57,p<0.05)。

结论

我们系列中患者的流行病学、临床和死亡率特征与文献中发表的最佳数据相似。该研究确定了几个在当地层面可用于估计脓毒症患者死亡风险的标志物。这样的研究对于改进脓毒症规范项目是必要的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71fa/6609936/0ce63d70ea00/revespquimioter-32-238-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71fa/6609936/ee4c1651adde/revespquimioter-32-238-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71fa/6609936/0ce63d70ea00/revespquimioter-32-238-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71fa/6609936/ee4c1651adde/revespquimioter-32-238-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71fa/6609936/0ce63d70ea00/revespquimioter-32-238-g002.jpg

相似文献

1
Initial clinical outcomes and prognostic variables in the implementation of a Code Sepsis in a high complexity University Hospital.一所高复杂性大学医院实施脓毒症代码的初始临床结果及预后变量
Rev Esp Quimioter. 2019 Jun;32(3):238-245. Epub 2019 Apr 9.
2
[Prognostic value of lipopolysaccharide binding protein and procalcitonin in patients with severe sepsis and septic shock admitted to intensive care].[脂多糖结合蛋白和降钙素原在入住重症监护病房的严重脓毒症和脓毒性休克患者中的预后价值]
Med Intensiva. 2015 May;39(4):207-12. doi: 10.1016/j.medin.2014.04.005. Epub 2014 Jun 18.
3
[Assessment values of procalcitonin, lactic acid, and disease severity scores in patients with sepsis].[降钙素原、乳酸及疾病严重程度评分在脓毒症患者中的评估价值]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 Aug;31(8):938-941. doi: 10.3760/cma.j.issn.2095-4352.2019.08.005.
4
[Clinical significance on serum intestinal fatty acid binding protein and D-lactic acid levels in early intestinal injury of patients with sepsis].[血清肠脂肪酸结合蛋白和D-乳酸水平在脓毒症患者早期肠道损伤中的临床意义]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 May;31(5):545-550. doi: 10.3760/cma.j.issn.2095-4352.2019.05.005.
5
[Intestinal barrier dysfunction and its related factors in patients with sepsis].[脓毒症患者的肠道屏障功能障碍及其相关因素]
Zhonghua Yi Xue Za Zhi. 2016 Nov 29;96(44):3568-3572. doi: 10.3760/cma.j.issn.0376-2491.2016.44.007.
6
Risk factors for mortality despite early protocolized resuscitation for severe sepsis and septic shock in the emergency department.急诊科对严重脓毒症和脓毒性休克进行早期规范化复苏后仍存在的死亡风险因素。
J Crit Care. 2016 Feb;31(1):13-20. doi: 10.1016/j.jcrc.2015.10.015. Epub 2015 Oct 26.
7
Early lactate clearance is associated with improved outcome in severe sepsis and septic shock.早期乳酸清除与严重脓毒症和脓毒性休克患者预后改善相关。
Crit Care Med. 2004 Aug;32(8):1637-42. doi: 10.1097/01.ccm.0000132904.35713.a7.
8
Predictive Value of Serum Albumin Level for the Prognosis of Severe Sepsis Without Exogenous Human Albumin Administration: A Prospective Cohort Study.血清白蛋白水平对未使用外源性人白蛋白的严重脓毒症患者预后的预测价值:一项前瞻性队列研究。
J Intensive Care Med. 2018 Dec;33(12):687-694. doi: 10.1177/0885066616685300. Epub 2016 Dec 26.
9
[Clinical characteristics and prognosis in patients with high plasma level of procalcitonin: an analysis in 188 patients].[血浆降钙素原水平升高患者的临床特征及预后:188例患者分析]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017 Jul;29(7):613-618. doi: 10.3760/cma.j.issn.2095-4352.2017.07.008.
10
Impact of the implementation of a Sepsis Code hospital protocol in antibiotic prescription and clinical outcomes in an intensive care unit.脓毒症代码医院协议的实施对重症监护病房抗生素处方及临床结局的影响。
Med Intensiva. 2017 Jan-Feb;41(1):12-20. doi: 10.1016/j.medin.2016.08.001. Epub 2016 Oct 19.

引用本文的文献

1
Decoding Sepsis: A 16-Year Retrospective Analysis of Activation Patterns, Mortality Predictors, and Outcomes from a Hospital-Wide Sepsis Protocol.解读脓毒症:一项对全院脓毒症治疗方案的激活模式、死亡率预测因素及结局的16年回顾性分析
J Clin Med. 2025 Aug 14;14(16):5759. doi: 10.3390/jcm14165759.
2
Decrease in Mortality after the Implementation of a Hospital Model to Improve Performance in Sepsis Care: Princess Sepsis Code.实施医院模式以改善脓毒症护理绩效后的死亡率下降:公主脓毒症代码。
J Pers Med. 2024 Jan 29;14(2):149. doi: 10.3390/jpm14020149.
3
Real Life Clinical Impact of Antimicrobial Stewardship Actions on the Blood Culture Workflow from a Microbiology Laboratory.

本文引用的文献

1
NEWS 2: an opportunity to standardise the management of deterioration and sepsis.新闻2:实现病情恶化和脓毒症管理标准化的契机。
BMJ. 2018 Mar 20;360:k1260. doi: 10.1136/bmj.k1260.
2
[Management of severe sepsis and septic shock in a tertiary care urban hospital emergency department: opportunities for improvement].[三级城市医院急诊科严重脓毒症和脓毒性休克的管理:改进的机会]
Emergencias. 2016;28(4):229-234.
3
[Before-after study of the effect of implementing a sepsis code for emergency departments in the community of Aragon].[阿拉贡社区急诊科实施脓毒症代码效果的前后对照研究]
抗菌药物管理措施对微生物实验室血培养工作流程的实际临床影响
Antibiotics (Basel). 2021 Dec 9;10(12):1511. doi: 10.3390/antibiotics10121511.
4
[Sepsis Code: dodging mortality in a tertiary hospital].[脓毒症规范:三级医院中规避死亡风险]
Rev Esp Quimioter. 2022 Feb;35(1):43-49. doi: 10.37201/req/105.2021. Epub 2021 Nov 23.
5
[Consensus document for sepsis code implementation and development in the Community of Madrid].[马德里社区脓毒症编码实施与制定共识文件]
Rev Esp Quimioter. 2019 Aug;32(4):400-409. Epub 2019 Jul 26.
Emergencias. 2017 Jun;29(3):154-160.
4
Evaluation of lactate, white blood cell count, neutrophil count, procalcitonin and immature granulocyte count as biomarkers for sepsis in emergency department patients.评估急诊科患者中乳酸、白细胞计数、中性粒细胞计数、降钙素原和未成熟粒细胞计数作为脓毒症生物标志物的情况。
Clin Biochem. 2017 Nov;50(16-17):956-958. doi: 10.1016/j.clinbiochem.2017.05.014. Epub 2017 May 25.
5
SOFA score in septic patients: incremental prognostic value over age, comorbidities, and parameters of sepsis severity.SOFA 评分在脓毒症患者中的应用:比年龄、合并症和脓毒症严重程度参数更具预后价值。
Intern Emerg Med. 2018 Apr;13(3):405-412. doi: 10.1007/s11739-017-1629-5. Epub 2017 Feb 10.
6
Early sepsis bundle compliance for non-hypotensive patients with intermediate versus severe hyperlactemia.非低血压性中度与重度高乳酸血症患者早期脓毒症集束化治疗的依从性
Am J Emerg Med. 2017 Jun;35(6):811-818. doi: 10.1016/j.ajem.2017.01.029. Epub 2017 Jan 15.
7
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.拯救脓毒症运动:脓毒症与脓毒性休克管理国际指南:2016版
Crit Care Med. 2017 Mar;45(3):486-552. doi: 10.1097/CCM.0000000000002255.
8
Towards precision medicine for sepsis patients.迈向脓毒症患者的精准医学
Crit Care. 2017 Jan 12;21(1):11. doi: 10.1186/s13054-016-1583-z.
9
Ready for Prime Time? Biomarkers in Sepsis.准备好进入黄金时代了吗?脓毒症中的生物标志物。
Emerg Med Clin North Am. 2017 Feb;35(1):109-122. doi: 10.1016/j.emc.2016.09.004.
10
Septic shock in the era of precision medicine.精准医学时代的脓毒性休克。
J Thorac Dis. 2016 Jun;8(6):1022-3. doi: 10.21037/jtd.2016.03.83.